|
|
40
|
|
|
A661D
|
|
|
RELPAX 40MG TAB (PFI/STO) ELETRIPTAN HBR
|
|
|
ELETRIPTAN HYDROBROMIDE
|
|
|
RELPAX
|
|
|
2'S
|
|
|
C
|
|
|
23.98
|
|
|
11.99
|
|
|
40MG
|
|
|
TABLET
|
|
|
0
|
|
|
TAB
|
|
|
PFI
|
|
|
PFIZER CORPORATION
|
|
|
STO
|
|
|
BRYDEN STOKES LTD
|
|
|
|
|
|
|
|
|
2022-04-01
|
|
|
2024-03-31
|
|
|
|
|
|
|
|
|
UAD
|
|
|
0
|
|
|
No
|
|
|
283228
|
|
|
SELECTIVE SEROTONIN AGONIST
|
|
|
|
|
|
Oral
|
|
|
0
|
|
|
CENTRAL NERVOUS SYSTEM DRUGS
|
|
|
|